HOME › DRUGS › DIHYDROCODEINE BITARTRATE
ACTIVE SUBSTANCE / INN

DIHYDROCODEINE BITARTRATE

Brand name(s): DHC PLUS, SYNALGOS-DC-A, ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE, SYNALGOS-DC, ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE, TREZIX
FDA LISTED
DISCONTINUED
ANDA040316
ANDA204209
ACTIVE SUBSTANCE
Dihydrocodeine Bitartrate
REGULATORS
FDA
SPONSORS / MAH
KEY THERAP, PHARMOBEDIENT, MIKART
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATEANDA204209PHARMOBEDIENTDiscontinued
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATEANDA040316MIKARTDiscontinued
SYNALGOS-DCNDA011483SUN PHARM INDUSTRIESDiscontinued
TREZIXANDA204785KEY THERAPDiscontinued
SYNALGOS-DC-AANDA089166LEITNER PHARMSDiscontinued
DHC PLUSANDA088584PHARM RES ASSOCDiscontinued

FULL INTELLIGENCE ON DIHYDROCODEINE BITARTRATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →